New UCLA-led research shows heart structure changes and cardiac biomarkers can predict breast, colorectal The post Your Heart ...

New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the ...

Daraxonrasib doubles survival — a RAS‑targeting drug development breakthrough.

A distinct signaling pathway called TNF- drives the transformation of epithelial cells into aggressive tumor cells. During cancer progression, cells activate their own TNF- program and become invasive ...

GLP-1 drugs aren’t just reducing weight — they may also be reducing the chances of developing one of the most common and deadliest cancers for women. Blockbuster weight loss drugs like Ozempic and ...

The gut microbiome plays a crucial role in cancer development and progression, by influencing the host immune system and metabolism. Dysbiosis, or a disruption in the balance of the host gut ...

Cancer drug development has never moved faster. Yet, for too many patients, the next treatment decision still begins with ...

A spate of new research suggests that GLP-1 drugs like Ozempic and Wegovy can protect you against cancers like in the lung ...

A massive 10-year population study reveals that neovascular age-related macular degeneration (nAMD) is linked to an increased ...

Withanolides, a class of naturally occurring compounds found in plants, have long been a focus of cancer research due to their ability to inhibit cancer cell growth, induce cell death and prevent ...